BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines
Agreement advances patient access and strengthens BeOne’s long-term commitment to U.S. innovation and manufacturing SAN CARLOS, Calif. — BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
